热门资讯> 正文
CEro Therapeutics任命Chris Ehrlich首席执行官
2024-12-06 23:12
- CERo Therapeutics Holdings (NASDAQ:CERO) has appointed Chris Ehrlich as CEO.
- Previously Ehrlich held the position of Interim CEO.
- In addition to his role at CERo, Ehrlich currently serves as CEO of Launch One Acquisition Corporation.
- CERO shares were down 29.5% on Friday.
- Source: Press Release
More on CERo Therapeutics Holdings, Inc.
- CERo Therapeutics says CEO Atwood, CFO Carter to step down
- Financial information for CERo Therapeutics Holdings, Inc.
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。